摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-Methoxy-6-(1-methylethoxy)pyridine | 1017577-25-1

中文名称
——
中文别名
——
英文名称
2-Methoxy-6-(1-methylethoxy)pyridine
英文别名
2-methoxy-6-propan-2-yloxypyridine
2-Methoxy-6-(1-methylethoxy)pyridine化学式
CAS
1017577-25-1
化学式
C9H13NO2
mdl
——
分子量
167.2
InChiKey
IKRUVXNRSDJIFA-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.1
  • 重原子数:
    12
  • 可旋转键数:
    3
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.44
  • 拓扑面积:
    31.4
  • 氢给体数:
    0
  • 氢受体数:
    3

文献信息

  • 8-AZABICYCLO[3.2.1]OCTANE-8-CARBOXAMIDE DERIVATIVE
    申请人:Horiuchi Yoshihiro
    公开号:US20120225876A1
    公开(公告)日:2012-09-06
    Disclosed is a compound represented by formula (1) or a pharmacologically acceptable salt thereof (In the formula, A represents a group that is represented by formula (A-1); R 1a and R 1b may be the same or different and each independently represents a C 1-6 alkyl group which may be substituted by one to three halogen atoms; m and n each independently represents an integer of 0-5; X 1 represents a hydroxyl group or an aminocarbonyl group; Z 1 represents a single bond or the like; and R 2 represents an optionally substituted C 1-6 alkyl group, an optionally substituted C 6-10 aryl group or the like.)
    公开了一种由公式(1)表示的化合物或其药理可接受的盐(在公式中,A代表由公式(A-1)表示的基团;R1a和R1b可以相同或不同,每个独立地表示一个可以由一个到三个卤素原子取代的C1-6烷基;m和n各自独立地表示0-5之间的整数;X1代表羟基或氨基甲酰基;Z1代表单键等;R2代表一个可选地取代的C1-6烷基,一个可选地取代的C6-10芳基等)。
  • SPIROPIPERIDINE ALLOSTERIC MODULATORS OF NICOTINIC ACETYLCHOLINE RECEPTORS
    申请人:Merck Sharp & Dohme Corp.
    公开号:US20220119351A1
    公开(公告)日:2022-04-21
    The present disclosure relates to compounds of formula (I) that are useful as modulators of 7α nAChR, compositions comprising such compounds, and the use of such compounds for preventing, treating, or ameliorating disease, particularly disorders of the central nervous system such as cognitive impairments in Alzheimer's disease, Parkinson's disease, and schizophrenia, as well as for L-DOPA induced-dyskinesia and inflammation.
  • US8933229B2
    申请人:——
    公开号:US8933229B2
    公开(公告)日:2015-01-13
查看更多